FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1658-1659 November 25, 1993 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Farley, M. M.

To the Editor: With regard to the article by Farley et al.¹ and the editorial by Wessels and Kasper² (June 24 issue): The defects in immune defenses in patients with cancer are extremely heterogenous in type and severity and cannot be simplistically characterized as specific defects in host immunity². A patient with Hodgkin's disease who is taking steroids and who has neutropenia after combination chemotherapy is quite different from a patient with a recent mastectomy for localized breast cancer. If cancer is to be considered a risk factor for an infectious disease, it would be worthwhile to attempt to . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.